Abstract
Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the general population. Given its multifactorial nature, the establishment of new risk factors associated with VTE is an essential step for better understanding the mechanisms involved in its pathophysiology. Among the risk factors, in recent years the role of tissue factor pathway inhibitor (TFPI) has been partic…